A new generation of calcium antagonists and their role in atherosclerosis

This publication has 20 references indexed in Scilit:

• In vitro inhibition of arterial myocyte growth and stimulation of low density lipoprotein metabolism by SIM 6080, a new calcium antagonist
  Pharmacological Research, 1990
• Effects of calcium antagonists on lipids and atherosclerosis
  The American Journal of Cardiology, 1989
• Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris
  The American Journal of Cardiology, 1989
• Antiatherogenic properties of calcium antagonists
  The American Journal of Medicine, 1989
• Densitometric measurement of increased endothelial permeability in arteriosclerotic plaques and inhibition of permeability under the influence of two calcium antagonists
  Atherosclerosis, 1989
• Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition — a pathogenic factor in atherosclerosis
  Atherosclerosis, 1988
• Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine
  Atherosclerosis, 1988
• Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
  The Tohoku Journal of Experimental Medicine, 1988
• Cardiovascular Drugs and Atherosclerosis
  Journal of Cardiovascular Pharmacology, 1988
• Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985